why choose us

First received: December 15, 2022

Clinical Trial: Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gastric Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Phase II Single-Arm, Window Trial of Tadalafil Effect + Chemotherapy in Patients With Resectable Gastric/GEJ Adenocarcinoma

Brief Summary: The goal of this clinical trial is to assess the ability of Tadalafil alone and in combination with neoadjuvant FLOT (5-Fluorouracil, Oxaliplatin, and Docetaxel) chemotherapy to suppress myeloid derived suppressor cells (MDSCs) in patients with resectable gastric or gastroesophageal junction adenocarcinoma.Resectable means the tumor may be removed through surgical intervention.Neoadjuvant chemotherapy is chemotherapy received before the primary course of treatment i.e.surgical intervention.The main questions it…

Read more